Analyses / Prediction Analysis / 119 · HR 3747 Prediction Analysis

119-HR-3747 DC Insider Prediction Analysis

119 · HR 3747 AADAPT Act

Enactment in 2026
55%
0%25%50%75%100%
Bipartisan AADAPT Act (H.R. 3747) to reauthorize and expand Project ECHO—including a new dementia-focused grant stream—advanced in E&C Health Subcommittee on May 13, 2026 and was taken up in Full Committee on May 21, 2026; with Republicans holding narrow House control and a GOP Senate (HELP chaired by Cassidy), the most likely path is House suspension, Senate unanimous consent, and enactment late 2026, though floor-time compression and potential Senate holds are real risks. [1]Congress.gov — All Information (Except Text) for H.R.3747 - AADAPT Act (119th)
House passage (next 4–8 weeks) 75 %
Senate passage (by end of 2026) 60 %
Enactment in 2026 55 %
Published
29 May 2026
Updated
29 May 2026
Tags
119th Congress · Health policy · Project ECHO
Unvetted
01 · Section

What the bill does and where it sits

- H.R. 3747 (AADAPT Act) reauthorizes the Project ECHO grant program in the Public Health Service Act and creates a dedicated Alzheimer’s/dementia training grant for primary care, with deadlines and reporting requirements. Key authorizations in the introduced text: $10M per year for general ECHO grants (FY2022–2032) and $1M per year for dementia ECHO (FY2027–2032). [2]GPO/Congress.gov — H.R. 3747 (119th): AADAPT Act — Introduced text (PDF)

  • Status: introduced June 5, 2025; referred to House Energy & Commerce (E&C). [1]Congress.gov — All Information (Except Text) for H.R.3747 - AADAPT Act (119th)
  • Recent movement: reported from E&C Health Subcommittee to Full Committee by voice vote on May 13, 2026; Full Committee held markup including H.R. 3747 on May 21, 2026. [3]House Energy & Commerce Committee (Republicans) — E&C Republicans: Health Subco…
  • Companion effort: advocacy materials list a Senate version (S. 4036); Senate action would route through HELP. [4]Alzheimer’s Impact Movement — Alzheimer’s Impact Movement: AADAPT Act page (not…
02 · Section

Institutional map and procedural lane

- Current alignment matters: Republicans hold a narrow House majority in the 119th Congress and a working majority in the Senate; the White House is Republican (Trump/Vance). That combination typically eases non-controversial health reauthorizations, provided floor time and holds are managed. [5]Encyclopaedia Britannica — United States House of Representatives overview and…

  • House pathway: most likely under Suspension of the Rules (Mon–Wed, no floor amendments, two‑thirds required). E&C clearance positions the bill for the suspension queue if leadership prioritizes it. [6]Congressional Research Service — CRS: Suspension of the Rules in the House — pr…
  • Senate pathway: referral to HELP (Chair Bill Cassidy). Non-controversial health reauthorizations often clear by unanimous consent; failing UC, cloture is 60 votes. [7]U.S. Senate HELP Committee — Senate HELP Committee: Cassidy seated as Chair for…
03 · Section

Passage probability (base case and drivers)

My read, as of May 29, 2026, weighing bipartisan framing, committee action, chamber control, and timing:

House passage (next 4–8 weeks)
75%
Senate passage (by end of 2026)
60%
Enactment in 2026
55%
  • Evidence of bipartisanship and policy modesty (reauthorization, small-dollar add-on) raise House odds if leadership gives floor time. [2]GPO/Congress.gov — H.R. 3747 (119th): AADAPT Act — Introduced text (PDF)
  • E&C Health Subcommittee advanced H.R. 3747 by voice vote on May 13, 2026; Full Committee considered it May 21—both signals of low controversy. [3]House Energy & Commerce Committee (Republicans) — E&C Republicans: Health Subco…
  • Senate prospects are helped by cross‑party Senate leads and a HELP chair (Cassidy) historically open to telehealth/education models; UC is plausible if no policy rider fight emerges. [4]Alzheimer’s Impact Movement — Alzheimer’s Impact Movement: AADAPT Act page (not…
04 · Section

Obstacles and risk factors

  • House floor-time squeeze: the summer work period is crowded (appropriations/NDAA), and suspension slots are finite; missing the pre-recess window can push action to September. [6]Congressional Research Service — CRS: Suspension of the Rules in the House — pr…
  • Two‑thirds threshold risk under suspension: if partisan friction spills over (e.g., unrelated leverage fights), leadership may need a rule instead, adding delay. [6]Congressional Research Service — CRS: Suspension of the Rules in the House — pr…
  • Senate holds: any one senator can object to UC; even friendly bills can idle unless time is burned to process them. [8]U.S. Senate — U.S. Senate: About Voting (cloture threshold; unanimous consent)
  • Calendar proximity to the 2026 midterms tends to crowd out smaller authorizations unless they ride a package (health extenders, omnibus, or year‑end UC stack). [9]congress.gov
05 · Section

Short‑term consequences if enacted

Operational impacts within 6–18 months of enactment, per bill text and context:

  • HHS/Secretary must stand up Alzheimer’s/dementia ECHO grants within one year of enactment for eligible primary‑care providers serving underserved areas. [2]GPO/Congress.gov — H.R. 3747 (119th): AADAPT Act — Introduced text (PDF)
  • Mandatory reporting by grantees to the Advisory Council on Alzheimer’s Research, Care, and Services; HHS to update Congress on program outcomes on specified timelines. [2]GPO/Congress.gov — H.R. 3747 (119th): AADAPT Act — Introduced text (PDF)
  • Scale is intentionally modest ($1M/yr for dementia ECHO, FY2027–2032), so near‑term visibility is likely via a small number of flagship networks rather than nationwide saturation. [2]GPO/Congress.gov — H.R. 3747 (119th): AADAPT Act — Introduced text (PDF)
06 · Section

Long‑term consequences (if implemented at scale)

Directional effects, acknowledging that realized impact depends on appropriations and program execution:

  • Better PCP readiness for earlier, more accurate dementia diagnosis in underserved settings—a gap repeatedly flagged by advocates—could shift portions of care from crisis to planned management. [4]Alzheimer’s Impact Movement — Alzheimer’s Impact Movement: AADAPT Act page (not…
  • Even incremental improvements in diagnosis/management have leverage against large caregiver and system costs; unpaid dementia caregiving value was estimated at roughly $446B in 2025, underscoring the fiscal context. [10]Alzheimer’s & Dementia (via PubMed Central) — 2026 Alzheimer’s Disease Facts &…
07 · Section

Forecast: most probable outcome and alternatives

  1. Most likely: House passes on suspension in June–July; Senate clears by UC in Q4; President signs in a year‑end health minibus or standalone UC sequence. Overall 55–60% by December 2026. [6]Congressional Research Service — CRS: Suspension of the Rules in the House — pr…
  2. Second path: House passes, Senate HELP reports, but UC objection forces floor time; bill rides a late‑year package (e.g., L‑HHS extenders). Timeline slips but outcome still >50/50. [9]congress.gov
  3. Lower‑probability: Floor time never materializes (House) or a Senate hold persists; measure resets for early 2027 or is refiled next Congress with revised pay-fors/authorizations. [6]Congressional Research Service — CRS: Suspension of the Rules in the House — pr…
08 · Section

Sourcing notes (key claims)

  • Bill text, program structure, and authorizations: GPO/Congress.gov bill PDF. [2]GPO/Congress.gov — H.R. 3747 (119th): AADAPT Act — Introduced text (PDF)
  • House status and cosponsors baseline: Congress.gov All‑Info page. [1]Congress.gov — All Information (Except Text) for H.R.3747 - AADAPT Act (119th)
  • Subcommittee action (5/13/26) and Full Committee markup (5/21/26): E&C majority and minority committee pages/releases. [3]House Energy & Commerce Committee (Republicans) — E&C Republicans: Health Subco…
  • Chamber control and leadership context: USAGov (President/VP), Senate party division; House narrow‑majority snapshots (Britannica). [11]USAGov (GSA) — USAGov: Presidents, vice presidents, and first ladies (current o…
  • Senate committee of referral and chair: Senate HELP (Chair Cassidy). [7]U.S. Senate HELP Committee — Senate HELP Committee: Cassidy seated as Chair for…
  • Advocacy confirmation of Senate companion: Alzheimer’s Impact Movement. [4]Alzheimer’s Impact Movement — Alzheimer’s Impact Movement: AADAPT Act page (not…
  • Epidemiology/economic context: 2026 Alzheimer’s Disease Facts & Figures (Alzheimer’s & Dementia, PMC). [10]Alzheimer’s & Dementia (via PubMed Central) — 2026 Alzheimer’s Disease Facts &…
  • Procedural thresholds: House suspension (CRS); Senate UC/cloture (Senate.gov). [6]Congressional Research Service — CRS: Suspension of the Rules in the House — pr…
Sources cited
  1. [1] All Information (Except Text) for H.R.3747 - AADAPT Act (119th) Congress.gov
  2. [2] H.R. 3747 (119th): AADAPT Act — Introduced text (PDF) GPO/Congress.gov
  3. [3] E&C Republicans: Health Subcommittee advances public health reauthorizations (incl. H.R. 3747) – May 13, 2026 House Energy & Commerce Committee (Republicans)
  4. [4] Alzheimer’s Impact Movement: AADAPT Act page (notes S. 4036) Alzheimer’s Impact Movement
  5. [5] United States House of Representatives overview and party totals (snapshot) Encyclopaedia Britannica
  6. [6] CRS: Suspension of the Rules in the House — principal features Congressional Research Service
  7. [7] Senate HELP Committee: Cassidy seated as Chair for 119th Congress U.S. Senate HELP Committee
  8. [8] U.S. Senate: About Voting (cloture threshold; unanimous consent) U.S. Senate
  9. [9] congress.gov
  10. [10] 2026 Alzheimer’s Disease Facts & Figures (journal article) Alzheimer’s & Dementia (via PubMed Central)
  11. [11] USAGov: Presidents, vice presidents, and first ladies (current officeholders) USAGov (GSA)

Discussion